These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23555730)

  • 21. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
    Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
    Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired amyloid β-degrading enzymes in brain of streptozotocin-induced diabetic rats.
    Liu Y; Liu L; Lu S; Wang D; Liu X; Xie L; Wang G
    J Endocrinol Invest; 2011 Jan; 34(1):26-31. PubMed ID: 20414044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic alteration of neprilysin and endothelin-converting enzyme in age-dependent APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhou L; Liu J; Dong D; Wei C; Wang R
    Am J Transl Res; 2017; 9(1):184-196. PubMed ID: 28123645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
    Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
    Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.
    Nalivaeva NN; Belyaev ND; Turner AJ
    Neurochem Res; 2016 Mar; 41(3):620-30. PubMed ID: 26376806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice.
    Carty NC; Nash K; Lee D; Mercer M; Gottschall PE; Meyers C; Muzyczka N; Gordon MN; Morgan D
    Mol Ther; 2008 Sep; 16(9):1580-1586. PubMed ID: 28189012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex.
    Pacheco-Quinto J; Eckman CB; Eckman EA
    Neurobiol Aging; 2016 Dec; 48():83-92. PubMed ID: 27644077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection induced by Navβ2‑knockdown in APP/PS1 transgenic neurons is associated with NEP regulation.
    Hu T; Li SS; Lu MN; Zhang L; Chen B; Mao R; Mei R; Tan YX; Li S; Xiyang YB
    Mol Med Rep; 2019 Aug; 20(2):2002-2011. PubMed ID: 31257483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
    Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
    Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating neprilysin clears brain amyloid.
    Liu Y; Studzinski C; Beckett T; Murphy MP; Klein RL; Hersh LB
    Mol Cell Neurosci; 2010 Oct; 45(2):101-7. PubMed ID: 20558294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid reduces neuritic plaque formation and improves learning deficits in APP(Swe) /PS1(A246E) transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin.
    Wang Z; Zhang XJ; Li T; Li J; Tang Y; Le W
    CNS Neurosci Ther; 2014 Mar; 20(3):209-17. PubMed ID: 24289518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
    Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
    Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
    Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice.
    Kwon H; Lee EH; Park SY; Park JY; Hong JH; Kim EK; Shin TS; Kim YK; Han PL
    Exp Mol Med; 2023 Sep; 55(9):2067-2082. PubMed ID: 37704750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease.
    Liu Y; Studzinski C; Beckett T; Guan H; Hersh MA; Murphy MP; Klein R; Hersh LB
    Mol Ther; 2009 Aug; 17(8):1381-6. PubMed ID: 19471248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.